The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from the safety lead-in for a phase II study of pembrolizumab in combination with binimetinib and bevacizumab in patients with refractory metastatic colorectal cancer (mCRC).
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - Foundation Medicine; Ipsen
Research Funding - Merck
Other Relationship - Immune Design
 
Sarah Lindsey Davis
No Relationships to Disclose
 
Stephen Leong
Stock and Other Ownership Interests - Antares Pharmaceuticals; Spectrum Pharmaceuticals
Honoraria - Lilly
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Alexis Diane Leal
No Relationships to Disclose
 
Patrick Jud Blatchford
No Relationships to Disclose
 
Gurprataap Singh Sandhu
No Relationships to Disclose
 
William T. Purcell
No Relationships to Disclose
 
Sunnie S. Kim
No Relationships to Disclose
 
Zoe Van De Voorde
No Relationships to Disclose
 
Rachel Telles
No Relationships to Disclose
 
Anne Martin
No Relationships to Disclose
 
Tiffany Cull
No Relationships to Disclose
 
Meredith Waring
No Relationships to Disclose
 
Colin Reed
No Relationships to Disclose
 
Chimmoua Lee
No Relationships to Disclose
 
Amanda Siedem
No Relationships to Disclose
 
Matthew R Lee
No Relationships to Disclose
 
Todd Pitts
Research Funding - AstraZeneca; Exelixis; Takeda
 
S. Gail Eckhardt
Stock and Other Ownership Interests - OnKure; Suvica
Honoraria - Guardant Health; Merck
Consulting or Advisory Role - CASI Pharmaceuticals; Kyowa Hakko Kirin; Merck; New B Innovation; OnKure; Suvica
Research Funding - OnKure (Inst); Revolution Medicines (Inst)
Patents, Royalties, Other Intellectual Property - One of the scientific collaborators at CU Boulder filed for a patent for one of his drugs.
Travel, Accommodations, Expenses - Guardant Health; Merck; New B Innovation
 
Wells A. Messersmith
Consulting or Advisory Role - Five Prime Therapeutics (Inst); Gilead Sciences (Inst); Purdue Pharma (Inst); Tanabe Research (Inst)
Research Funding - Aduro Biotech (Inst); Alexo Therapeutics (Inst); AstraZeneca (Inst); Beigene (Inst); D3 (Inst); Immunomedics (Inst); OncoMed (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)